Pulmonologist-Administered Balanced Propofol Analgosedation during Interventional Procedures: An Italian Real-Life Study on Comfort and Safety

Table 3

Demographic data and comorbidities and physiological parameters before and after VFB procedure.

Demographic data and comorbidities	Mean (SD)
Age	67 (SD ± 14)
Weight	71 (SD ± 14)
	% (n)
Male (%)	64 (101)
Chronic respiratory failure	6 (15)
COPD	9 (20)
CAD	4 (10)
CHD	2 (5)
Systemic arterial hypertension	23 (54)
Arrhythmias	6 (15)
Diabetes mellitus	8 (19)
Chronic liver disease	2 (59)
Malignancies	11 (26)
Chronic renal diseases (%)	9 (4)
Physiological parameters	Before VFB mean (SD)	After VFB mean (SD)
SBP (mmHg)	137 (±23)	127 (±21)
DBP (mmHg)	75 (±13)	73 (±12)
HR (ppm)	78 (±14)	81 (±15)
SatO2 (%)	96 (±2)	95 (±3)
RR (bpm)	18 (±4)	17 (±4)

SD: standard deviation; age in years; weight in kg; COPD: chronic obstructive pulmonary disease; CAD: coronary artery disease; CHD: chronic heart disease; VFB: video-fiber-bronchoscope; SBP: systolic blood pressure; DBP: systolic blood pressure; HR: heart rate; SatO2: oxygen saturation; RR: respiratory rate.